Spiroindalones
US8309544B2 · kind B2 · utility
0Cited by
1References
3Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 12, 2008 |
| Grant date | Nov 13, 2012 |
| Priority date | — |
| Expiry date | Jul 22, 2028 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P7/06
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to spiroindalone compounds useful as HIF prolyl hydroxylase inhibitors to treat anemia and like conditions.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.